Midland Park, NJ (PRWEB) November 10, 2012
Barry Brandman, CEO of Danbee Investigations, Midland Park, NJ, will speak about “Security Best Practices and C-TPAT” on November 14, 2012. The PDA/FDA Pharmaceutical Supply Chain Conference is being held at the Bethesda, MD North Marriott Hotel and will be attended by government officials and senior business executives from across the country.
Three critical security risks facing the pharmaceutical industry today are internal theft, counterfeiting and terrorism.
Since 2004, there have been over 600 reported attempts to penetrate the global supply chain. In light of recent geopolitical events, many experts expect this risk to increase in the immediate future.
Additionally, organized crime is responsible for hundreds of millions of dollars of theft related loss each year, while counterfeit drugs pose an extremely serious health risk to the public.
“Pharmaceutical manufacturers and distributors, as well as their logistics providers, are extremely interested in knowing how to effectively protect their companies from internal and external security threats,” explains Mr. Brandman. “Maintaining highly secure supply chains that can withstand sabotage, tampering, theft, and counterfeiting is absolutely essential to a company’s reputation and product integrity. Not integrating the very Best Practices into your pharmaceutical supply chain carries significant consequences.”
About Danbee Investigations:
Danbee Investigations is regarded as one of the nation’s most respected security consulting and investigation companies. Their clients include Fortune 100 companies as well as major privately held firms. Danbee Investigations specializes in inventory loss, fraud, product tampering, counterfeiting and product diversion, as well as helping companies obtain government security certifications such as C-TPAT. (http://www.danbeeinvestigations.com/security-consultants-corporate-investigations).
Barry Brandman is the author of three security manuals and has been a guest speaker for numerous organizations, including the U.S. Department of Homeland Security, the National Association of Chain Drug Stores, the Healthcare Institute for International Research, and the Council of Supply Chain Management Professionals.
About the Parenteral Drug Association (PDA):
The PDA is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a non-profit organization, PDA is committed to developing scientifically sound technical information and resources to advance science and regulation through the expertise of it’s more than 9,500 members worldwide.